Animal Health latest news-Sept.

Ourofino to obtain the GPTW certification, Biogénesis Bago activities in Bolivia and Brazil, CDV new facilities as a result of their growth, FDA announced that it has launched the Animal and Veterinary Innovation Agenda (AVIA), innovation in Zoetis and Elanco, new approval for MSD and other news, Norbrook with new CEO.

?? Elanco Animal Health Incorporated announced the launch of Varenzin-CA1 (molidustat oral suspension), conditionally approved by the FDA as the first and only treatment to control non-regenerative anemia in cats with chronic kidney disease. (company press release)

?? At Biogénesis Bagó Brazil, after traveling through Goiania (GO) visiting large feedlots, the team attended the Feedlot Summit. The Marketing Manager for Brazil and Latin America, Carlos Eduardo Godoy, emphasizes the value of this environment for making contacts and expanding the networking. The Feedlot Summit is organized in Goiania (GO) by COAN Consultoria Avan?ada em Pecuária Ltda. (Portal Feed&Food, Set. 18).

?? Ourofino Saúde Animal is the 3rd Best Company to Work for in S?o Paulo. For yet another consecutive year, the company has achieved the Great Place to Work certification, ranking among the best. Once again, they are among the best companies to work for in the category of Large Companies in the Interior of S?o Paulo, according to GPTW. This award reflects the collective effort of everyone at Ourofino and their ongoing commitment to creating an exceptional work environment where everyone can thrive and grow (Linkedin da Companhia, Set. 18).

?? The FDA announced that it has launched the Animal and Veterinary Innovation Agenda (AVIA) as a way to modernize the way the FDA evaluates and supports the development of innovative animal and veterinary products. The guidelines break for a list of 4 objectives and details that will support actions by the Center for Veterinary Medicine (CVM) to strengthen product development and put into place smart, risk-based approaches as a way to regulate modern animal and veterinary products. The FDA is planning to go through its animal and veterinary product review programs and projects to reassess and adjust them as needed to account for the diversity of developed products using innovative technologies. (dvm360.com, Sept. 18th).

?? Zoetis Argentina is making strides in the local market, bringing innovations related to pain management and its line of antiparasitic products for companion animals. In the case of biologics, the Vanguard line focuses on disease prevention, with full support from its technical team. Additionally, in the realm of antiparasitic products, there is the presence of Simparica. Furthermore, Zoetis is also expanding its presence in other market segments such as dermatology and diagnostics. Juliana Stalzer announced that the company will be expanding the possibilities of monoclonal antibody therapies to treat pain in dogs and cats. (Motivar.com.ar, Sept. 19th).

?? Elanco Saúde Animal is launching Elancovets, a relationship and support program aimed at veterinarians specializing in small animals (pets). This program offers technical content, online training, participation in events, technical visits from representatives, innovative products, and a range of services designed to add value to the work of veterinarians and to the management of their businesses, whether they are independent professionals or part of clinics and veterinary hospitals. According to the latest survey by the Pet Animal Commission of the National Union of Animal Health Product Industries (Comac) - Comac 2022 Annual Report - there are more than 47,000 establishments currently providing veterinary healthcare services in Brazil. The report states that "between 2017 and 2022, there was a strong expansion in the number of specialized hospitals, with more than double the units, and clinics saw significant growth of 78%. (caesegatos.com.br, Set 12).

?? Walmart announced the opening of a dedicated pet services center in a suburb of Atlanta, Georgia, offering veterinarian visits and dog grooming appointments. The first-of-its-kind center will have its own dedicated entrance next to a store and will carry the Walmart name; but will be staffed by employees of PetIQ, which rents space for vet clinics inside more than 65 Walmart stores. The Georgia location will serve as a pilot, but Walmart plans to open more locations. (CNBC)

?? CDV Argentina, is making progress in the construction of its new veterinary vaccine plant in Argentina. This plant, which has already begun construction, will meet the highest international standards of quality and sustainability. Given the imminent increase in global food demand, there is a growing need to improve the sustainable use of natural resources, such as veterinary vaccines. This new plant is being developed in conjunction with two other facilities that are being refurbished. All of them will comply with the requirements set by the international classification of world-class manufacturing for the production of animal vaccines. The plant has been designed with the vision of adopting "green industry" characteristics, with the goal of maximizing efficiency in its production process. (Motivar.com.ar, Sept. 23).

?? MSD Animal Health, a division of Merck & Co. announces that the European Commission has approved INNOVAX-ILT-IBD, a trivalent vector vaccine that provides long-term protection against infectious laryngotracheitis (ILT), infectious bursal disease (IBD), and Marek's disease (MD) in Spain. Building on the protective legacy of MSD Animal Health offered by INNOVAX-ILT, INNOVAX-ILT-IBD features two ILT glycoprotein inserts instead of one. Furthermore, clinical trial data shows that INNOVAX-ILT-IBD has an early onset and long-lasting immunity. INNOVAX-ILT-IBD is the first and only vaccine approved in the European Union to provide combined protection against the development of ILT, IBD, and MD in a single injection. This approval follows a positive opinion from the Committee for Veterinary Medicinal Products (CVMP) received in April 2023. (interempresas.net, Sept.).

?? GERMANY Zoetis Inc. announced it has acquired 100% of the shares of German biotech company adivo GmbH. adivo, which spun off from MorphoSys AG in 2018, develops animal-specific therapeutic antibodies using two patent-protected technology platforms. Financial terms were not disclosed. (Biopharmadive.com)

?? The Biogénesis Bagó team in Bolivia hosted "Reproduz+," an exclusive event for producers, veterinarians, and clients where they discussed the main trends and solutions to optimize reproductive indices. During the event, the team shared technical knowledge, the latest innovations in the industry, and presented their extensive portfolio of solutions, providing support and training to those involved in animal production. Through their "Produz+" campaign, they reaffirm their commitment to farmers and veterinary professionals, contributing to achieving more efficient production. (Company's LinkedIn, September).

?? Norbrook Laboratories Ltd. have appointed Italian Andrea Iucci, formerly Senior Vice President and Corporate Office, EMEA in IDEXX, as the firm’s new CEO. He will take over from the current CEO, Liam Nagle, who will step down at the end of the year. Mr Nagle, who joined the firm in 2015, will remain as Chairman. Mr Iucci’s appointment was the conclusion of an extensive global search process led by a subset of the Board and supported by an executive search firm. (northernirelandworld.com, Sept 15th).

?? Calier Punta Cana 2023. In September, under the slogan "Together we do it differently, together we do it Calier," staff from all our subsidiaries (Spain, Argentina, Dominican Republic, Portugal, Ecuador, Italy, Poland, and Uruguay) gathered in Punta Cana to work on the different lines and the future business plan of Calier. (Company's LinkedIn, Sept 22). Calier, the veterinary laboratory of the Indukern Group, continues to strengthen its commitment to the digital environment with the launch of its new profile on Instagram. From @calier_es, the laboratory aims to be closer to its stakeholders: veterinarians, pet owners, and society in general. Through this new channel, Calier will share with its followers its project, the species it focuses on—poultry, livestock, beekeeping, and companion animals—as well as its main actions and projects. It will also introduce its facilities and its human team, key players in Calier's development. (animalshealth.es, Sept).

?? IRELAND VistaMilk announced it has developed chipless, electronics-free cow health monitors that do not need battery power to send data to computers or mobile devices. The developers say the devices will allow for ear tags or skin patches to transmit data read by scanners. (Farmersjournal.ie)

?? VetPartners and Vetoquinol They are celebrating the first webinar of the Applied Dermatology in Clinical Practice Course. The course's objective is to refresh the basic knowledge of veterinary teams at VetPartners in managing the main dermatological pathologies. Recently, the first webinar of the Applied Dermatology in Clinical Practice Course, organized by the training team of the VetPartners group of veterinary centers in collaboration with Vetoquinol Spain, was held. The course, which is entirely e-learning and divided into three separate seminars, covers the management of wounds with real cases and the available therapeutic options for achieving optimal wound closure. (animalshealth.es, Sept 21).

www.animalhealthnexus.com ?? NEXUS ANIMAL HEALTH

??+59899728874 BERNARDO OTERO